Debra Hart | Head of IR |
Carl Hull | Executive Chairman of the Board |
Trey Martin | CEO |
Kevin Herde | CFO |
Becky Buzzeo | CCO |
Drew Burch | EVP, and GM Nucleic Acid Production |
Matt Sykes | Goldman Sachs |
Conor McNamara | RBC Capital Markets |
Dan Leonard | Credit Suisse |
Catherine Schulte | Baird |
Justin Bowers | Deutsche Bank |
Tejas Savant | Morgan Stanley |
Madeline Mollman | William Blair |
John Sourbeer | UBS |
Thank you for standing by. I would like to welcome everyone to the Quarter Two 2023 Maravai LifeSciences' Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I will now turn the conference over to Debra Hart.